Clinical Trials Browser

OTHER × Neoplasm Metastasis × enfortumab vedotin × Clear all

NCT07183319 2026-02-02

Circulating Tumor DNA Response In Urothelial Cancer

Phase 2 Recruiting

Carcinoma, Transitional Cell, Neoplasm Metastasis